Abbott Receives Emergency Use Authorization For COVID-19 Test

Abbott has become the next major diagnostics company to receive an Emergency Use Authorization from the US FDA for a COVID-19 test.  

MT1901_Abbott_ 712414345 _1200.jpg

The US Food and Drug Administration has issued Emergency Use Authorization (EUA) to Abbott Laboratories Inc. for a COVID-19 test, the company announced 18 March.

Abbott said it will ship 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the US and ramp up production, with the goal of providing up to one million...

More from In Vitro Diagnostics

More from Diagnostics